A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

Not Applicable

Completed

• Conditions: Glucosephosphate Dehydrogenase Deficiency; Favism

• Registration Number: NCT00076323
• Lead Sponsor: Walter Reed Army Institute of Research (WRAIR)

Brief Summary

This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-12
• Study First Submitted: 2004-01-20
• Study First Submitted QC: 2004-01-20
• Study First Posted: 2004-01-21
• Study Completion: 2006-11
• Status Verified: 2010-07
• Last Update Submitted: 2010-07-26
• Last Update Posted: 2010-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Difference in degree of hemolysis of G6PD(-) red blood cells in treated vs untreated matched samples.

Trial Locations

Locations (1)

Walter Reed Army Institute of Research; 🇺🇸 Silver Spring, Maryland, United States